Navigation Links
UBM Medica's Cancer Management: A Multidisciplinary Approach Now Updated Online
Date:1/11/2012

NORWALK, Conn., Jan. 11, 2012 /PRNewswire/ -- UBM Medica's widely acclaimed and trusted cancer care reference book Cancer Management: A Multidisciplinary Approach, 14th edition, is now available online. This guide is designed to present important clinical information concisely, uniformly, and logically, emphasizing the natural history of the malignancy, screening and diagnosis, staging and prognosis, and treatment of cancers.

Key features of this updated edition of the reference work include:

  • A truly integrated, multidisciplinary approach to the management of the patient with cancer
  • Discussions of each disease site, combining the perspectives of medical oncology, surgical oncology, and radiation oncology where appropriate
  • New this edition: Daniel Haller, MD, Emeritus Professor of Medicine at the Abramson Cancer Center at the University of Pennsylvania and past Editor in Chief of Journal of Clinical Oncology, joins as lead medical editor for the book

Dr. Haller is joined by long-standing medical editors Lawrence D. Wagman, MD, Center for Cancer Prevention and Treatment, St. Joseph Hospital, Kevin A. Camphausen, MD, National Cancer Institute, and William J. Hoskins, MD, Memorial Sloan-Kettering Cancer Center.

Jointly authored by over 100 distinguished medical, surgical, and radiation oncologists from over 45 medical institutions throughout the United States, this illustrated handbook offers over 1,000 pages of the latest facts on the management of all cancers. This fully indexed sourcebook expands on the most current techniques on screening, diagnosing, staging, prognoses, treatments, and outcomes. Written for both the clinician and patient, the 14th edition also fully presents new information on newly approved FDA drugs and clinical trials, and the latest data from the AJCC Staging Manual. More than 3,400 cancer professionals have provided unanimous praise for the usefulness and thoroughness of this noteworthy reference sourcebook.

"Cancer Management: A Multidisciplinary Approach represents the best of medical education for hematologists and oncologists: the best authors, up-to-date, and concise enough to be usable for clinicians. The online version extends this usefulness for anyone and everywhere in the clinic," says Dr. Haller.

About UBM Medica

Addressing today's healthcare information needs, UBM Medica, a division of UBM plc (UBM.L), delivers strategic, integrated communications solutions and comprehensive reach—online, in print, live, and via custom programs. Improving the effectiveness of healthcare through information and education, UBM Medica provides unbiased clinical, practical, and business information for physicians, providers, payers, and patients around the world. Through journals, magazines, websites, drug databases, data services, live events, and other valuable resources, UBM Medica also delivers comprehensive communication solutions for the pharmaceutical and related industries. US websites include PsychiatricTimes.com, CancerNetwork.com, DiagnosticImaging.com, ConsultantLive.com, OBGYN.net, PhysiciansPractice.com and SearchMedica.com.  Employing more than 1,400 people with offices in 29 countries, UBM Medica is headquartered in London.  For more information, visit http://www.ubmmedica.com/

Media contact:
Amy Erdman
Marketing Director
203-523-7041
amy.erdman@ubm.com


'/>"/>
SOURCE UBM Medica
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. Novel Technology Breaks Through Cancer Pain
8. CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug
9. Furamidine Found to Inhibit a Key Enzyme Involved in Cancer Cell DNA Repair Mechanisms
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology:
(Date:6/26/2016)... Lake Orion, Clarkston, Michigan (PRWEB) , ... June ... ... direction with respect to fertility once they have been diagnosed with endometriosis. These ... tolerable intercourse but they also require a comprehensive approach that can help for ...
(Date:6/25/2016)... FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial ... Plant City Observer , brings up a new, often overlooked aspect of head lice: the ... closing for fumigation is not a common occurrence, but a necessary one in the event ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
Breaking Medicine News(10 mins):